AKUMS — Akums Drugs and Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹148.05bn
- IN₹150.94bn
- IN₹41.78bn
Annual cashflow statement for Akums Drugs and Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | PROSPECTUS |
| Standards: | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | 1,723 | -1,932 | 1,503 | -453 |
| Depreciation | ||||
| Non-Cash Items | 752 | 5,367 | 449 | 4,305 |
| Unusual Items | ||||
| Equity in Net Earnings/Losses | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | -1,862 | -4,064 | -1,314 | -129 |
| Change in Accounts Receivable | ||||
| Change in Inventories | ||||
| Change in Other Assets | ||||
| Change in Accounts Payable | ||||
| Change in Other Liabilities | ||||
| Other Operating Cash Flow | ||||
| Cash from Operating Activities | 1,311 | 319 | 1,766 | 4,979 |
| Capital Expenditures | -828 | -2,576 | -3,288 | -3,114 |
| Purchase of Fixed Assets | ||||
| Other Investing Cash Flow Items | -266 | 228 | 241 | -190 |
| Sale of Fixed Assets | ||||
| Sale/Maturity of Investment | ||||
| Change in Net Investments | ||||
| Purchase of Investments | ||||
| Other Investing Cash Flow | ||||
| Cash from Investing Activities | -1,094 | -2,348 | -3,047 | -3,304 |
| Financing Cash Flow Items | -50.2 | -89.1 | -404 | -434 |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | -915 | 2,360 | 1,245 | -1,080 |
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | -697 | 331 | -35.3 | 594 |